Since Beckman Coulter began to develop in China more than 40 years ago,  it has continued to increase local investment, firmly helped China's laboratory medicine, realized the localization of a number of products, and is committed to promoting leading science and technology to more people.

Entering a new stage, adhering to the value concept of "in China, for China", Beckman Coulter deepened its development strategy in China, and officially released a localized innovative brand - "Beihuakang" and its first product, the automatic sample processing system ADX-E1, on June 24, 2022, fully demonstrating its long-term commitment to deeply explore the Chinese market.

As an international IVD company that entered China early and built factories in China, Beckman Coulter launched the "Beihuakang" brand with the meaning of "committed to Chinese health", aiming to select high-quality localized IVD partners. Jointly customize excellent, intelligent and comprehensive diagnostic products and smart laboratory solutions, which are closer to the needs of the local market and better serve Chinese customers.